Editor's Picks

Expert Group Approves Safety, Efficacy of GSK’s Malaria Drug

“I thought the efficacy data was very strong,” said committee member Dean Follmann, assistant director for biostatistics at the National Institute of Allergy and Infectious Diseases. “When we do a pooled analysis to compare it to primaquine we see they’re very similar.” Read More